Mathematical Modelling within Radiotherapy: The 5 R’s of Radiotherapy and the LQ model. Helen McAneney 1 and SFC O’Rourke 1,2 1 School Mathematics and.

Slides:



Advertisements
Similar presentations
بسم الله الرحمن الرحيم ﴿و قل رب زدنى علماً﴾ صدق الله العظيم.
Advertisements

Genetic Susceptibility Can we identify cells, individuals or subpopulations that are genetically susceptible to radiation?
Modifiers of Cell Survival: Repair
A Phase III Prospective Randomized Trial of Acupuncture for Treatment of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer CCOP Investigators’
Biologiske modeller i stråleterapi Dag Rune Olsen, The Norwegian Radium Hospital, University of Oslo.
Ahmed Group Lecture 6 Cell and Tissue Survival Assays Lecture 6.
Bio 130 Human Biology Cancer Normal cells have regulation that keeps their rates of cell division in check. Normal cells generally remain in one location.
Modifiers of Cell Survival: Oxygen Effect
‘A little to a lot or a lot to a little’ ­ the crucial question to be raised in conformal radiation therapy Professor Dag Rune Olsen, PhD Institute for.
Some remaining questions in particle therapy radiation biology Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology 2.
Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.
Physical optimization criteria Target objective function N t = number of voxels in target D i = dose to voxel i D presc = prescribed dose to target D min.
Fractionation and tumor control: applying mathematical models derived from radiobiology to the clinics Bleddyn Jones.
Mary McCormack & Jonathan Ledermann NCRI Gynae Clinical Studies Group.
BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,
Radiotherapy for Kidney cancer
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;
Time, Dose, and Fractionation
RESPONSE OF A RESISTANT HUMAN MELANOMA CELL LINE TO A THERAPEUTIC PROTON BEAM A. Ristić-Fira 1, I Petrović 1, D. Todorović 1, L. Korićanac 1, L. Valastro.
Mathematical Modelling of Radiotherapy: Applying the LQ model. Helen McAneney 1,2 & SFC O’Rourke 2 1 School of Medicine, Dentistry and Biomedical Sciences.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 100 Basic Principles of Cancer Chemotherapy.
Sequential vs. concurrent chemoradiotherapy for locally advanced non-small cell carcinoma.
Predictive models validated by clinical data: new strategies for fractionation Dr. M. Benassi Dr. S. Marzi.
Tumors Models, and Response of Tumors Martin Brown April 23, 2012
TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.
First Year Workshop 2014 Miriam Lafiandra
Insert Program or Hospital Logo Introduction Melanoma is notoriously resistant to chemotherapy. While surgical resection and adjuvant chemotherapy can.
INT Translational research in head and neck cancer: preoperative chemotherapy in oral cavity cancer based on disease molecular profiling. Paolo Bossi MSO.
IMRT QA Plan Site 5%/3mm3%/3mm2%/2mm 0% noise1% noise2% noise0% noise1% noise2% noise0% noise1% noise2% noise HN
Bayesian Analysis and Applications of A Cure Rate Model.
Vischioni Barbara MD, PhD Centro Nazionale Adroterapia Oncologica
Validity of more than 30Gy radiation therapy for long-surviving patients with painful bone metastases E.Katayama 1,2, H.Okada 1, I.Asakawa 2, T.Tamamoto.
N.B. for a given fraction size
Training Module 3 – Version 1.1 For Internal Use Only ® Radiation Therapy 
A Tumour Control Probability based approach to the development of Plan Acceptance Criteria for Planning Target Volume in Intensity Modulated Radiation.
24/09/041 SIR and the Management of Cancer Trial Data Kate Motohashi Gray Cancer Institute, Northwood, UK.
RADIATION PROTECTION IN RADIOTHERAPY
Hormone treatment combined with radiotherapy
Introduction to Radiation Therapy
Karolina Kokurewicz Supervisors: Dino Jaroszynski, Giuseppe Schettino
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
TEMPLATE DESIGN © Optimization of Cancer Radiation Treatment Schedules Jiafen Gong* and Thomas Hillen Department of Mathematical.
Oxygen and Cancer: friend or foe?. Part 1: Scientific part Dirk de Ruysscher Part 2: Organisational part Harald Moonen.
UNIVERSAL SURVIVAL CURVE AND SINGLE FRACTION EQUIVALENT DOSE: USEFUL TOOLS IN UNDERSTANDING POTENCY OF ABLATIVE RADIOTHERAPY CLINT PARK, M.D. M.S., LECH.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 13: Multiple, Logistic and Proportional Hazards Regression.
Department of Clinical Radiotherapy, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK R4 한재준 1.
Basic Clinical Radiobiology Ch. 5 Dose–response relationships in radiotherapy SØREN M. BENTZEN.
RBE: open issues and next challenges Francesco Tommasino Workshop: la radiobiologia in INFN Trento, Maggio 2016.
PD-L1 expression patterns in the metastatic tumors to the lung: a comparative study with the primary non-small cell lung cancer Zoran Gatalica1*, Jude.
Combined effect of charged particles irradiation and anticancer drugs in cultured tumor cells.(RDH_IRPT WP2; INFN_Milano, CNAO and Istituto Tumori) The.
Computer modelling using cellular automata of the survival fraction of cell populations under irradiation Morgiane Richard Examples.
Hypofractionated radiotherapy for breast cancer
Compassionate People World Class Care
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
L M Smyth, P A Rogers, J C Crosbie & J F Donoghue
Y. Yan1, V. Adhikarla1, M. W. Kissick1,2, D. Campos1, D. H. Zhao1, S
Introduction to clinical Radiotherapy
Basic Principles of Cancer Chemotherapy
Genetic Susceptibility
Figure 5 Schematic illustration of different clinical trial designs
Figure 6 Double opposed-field irradiation of an idealized geometry
RADIOBIOLOGY Agnieszka Żyromska.
Nat. Rev. Urol. doi: /nrurol
Figure 5 The biological effects of charged particles
Figure 3 Drug cycling with collateral sensitivity
Figure 2 Host immune responses, not the radiosensitivity
Turning Gray: The Natural History of Lung Cancer Over Time
Figure 2 Dominance of the cell-extrinsic effects of autophagy
Modeling and Prediction of Cancer Growth Louisa Owuor, Dr. Monika Neda
Principles of Radiation Therapy
Presentation transcript:

Mathematical Modelling within Radiotherapy: The 5 R’s of Radiotherapy and the LQ model. Helen McAneney 1 and SFC O’Rourke 1,2 1 School Mathematics and Physics, Queen’s University Belfast, 2 Centre for Cancer Research and Cell Biology Introduction Radiotherapy is still second after surgery in the fight against cancer as well as being much cheaper than chemotherapy. Modelling is therefore crucial in advancing this form of treatment, with previous models assuming total population dynamics and general tumour types. Following earlier work 1, presented here are specific calculations on a 2-compartment system of oxic and hypoxic cells with the LQ model extended to account for 4 R’s of radiotherapy (repopulation, repair, redistribution and re-oxygenation) under various treatment schedules for particular tumour types.Introduction References: 1.H McA & SFC O’R, Phys. Med. Biol. 52 (2007) JJ Kim & IF Tannock, Nature Cancer Review 5 (2005) DJ Brenner et al. Int. J. Radiat. Oncol. Biol. Phys. 32 (1995) JA Horas, OR Olguin & MG Rizzotto, Phys. Med. Biol. 50 (2005) FM Buffa et al. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) References: 1.H McA & SFC O’R, Phys. Med. Biol. 52 (2007) JJ Kim & IF Tannock, Nature Cancer Review 5 (2005) DJ Brenner et al. Int. J. Radiat. Oncol. Biol. Phys. 32 (1995) JA Horas, OR Olguin & MG Rizzotto, Phys. Med. Biol. 50 (2005) FM Buffa et al. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) Conclusions Although further investigation is required, for those results presented it should be noted that Again the type of repopulation impacts on the success of treatment with Gompertzian re-growth being least favourable for the patient in both fixed and dynamic radio-sensitivity parameters Logistic and exponential re-growth produces similar results, though one order of magnitude better in tumour eradication if cellular diversity is accounted for rather than fixed dynamics. Thus radio resistance due to hypoxia and quiescent nature of tumour are important factors to consider. Future questions to be addressed include Does the level of heterogeneity play a significant role? Does the choice of parameters significantly effect these conclusions? Intrinsic radio-resistance of cells needs to be addressed.Conclusions Although further investigation is required, for those results presented it should be noted that Again the type of repopulation impacts on the success of treatment with Gompertzian re-growth being least favourable for the patient in both fixed and dynamic radio-sensitivity parameters Logistic and exponential re-growth produces similar results, though one order of magnitude better in tumour eradication if cellular diversity is accounted for rather than fixed dynamics. Thus radio resistance due to hypoxia and quiescent nature of tumour are important factors to consider. Future questions to be addressed include Does the level of heterogeneity play a significant role? Does the choice of parameters significantly effect these conclusions? Intrinsic radio-resistance of cells needs to be addressed. The LQ model & Repopulation Repopulation of cancer cells during therapy can be an important cause of treatment failure, both for radiotherapy and chemotherapy 2. This is often taken as exponential in nature, though there is evidence to suggest that growth is limiting, e.g. Gompertzian or logistic in nature (See figure 1). Figure 1: (left) Human lung data showing Gompertzian pattern of growth, taken from Steel. (right) Illustration of types of growth laws The linear-quadratic (LQ) model is the most commonly used approach to study the response of cells to radiation: SF denotes surviving fraction, D the dose in Gys, G the Lea-Catcheside function (G  1 for acute exposure)  is characteristic of tissue type. This model considers the effect of both irreparable damage and repairable damage susceptible to misrepair which ultimately leads to mitotic cell death. Inclusion of repopulation with treatment protocols led to following conclusions: Gaps in treatment allow differences in growth laws to emerge Survival Fraction endpoint (See Table 1) - Logistic and Exponential similar order of magnitude - Differences of larger for Gompertz No. of cells in tumour, means this has a larger potential to repopulate tumour Faster the doubling time, more apparent differences become Limited re-growth leading to poorer prognosis for tumour eradication is NOT intuitive The LQ model & Repopulation Repopulation of cancer cells during therapy can be an important cause of treatment failure, both for radiotherapy and chemotherapy 2. This is often taken as exponential in nature, though there is evidence to suggest that growth is limiting, e.g. Gompertzian or logistic in nature (See figure 1). Figure 1: (left) Human lung data showing Gompertzian pattern of growth, taken from Steel. (right) Illustration of types of growth laws The linear-quadratic (LQ) model is the most commonly used approach to study the response of cells to radiation: SF denotes surviving fraction, D the dose in Gys, G the Lea-Catcheside function (G  1 for acute exposure)  is characteristic of tissue type. This model considers the effect of both irreparable damage and repairable damage susceptible to misrepair which ultimately leads to mitotic cell death. Inclusion of repopulation with treatment protocols led to following conclusions: Gaps in treatment allow differences in growth laws to emerge Survival Fraction endpoint (See Table 1) - Logistic and Exponential similar order of magnitude - Differences of larger for Gompertz No. of cells in tumour, means this has a larger potential to repopulate tumour Faster the doubling time, more apparent differences become Limited re-growth leading to poorer prognosis for tumour eradication is NOT intuitive The 2-compartment LQR model & Repopulation Extending the LQ model to include: Redistribution - Asynchronous cycling cell population, preferentially spare cells in resistant part of cell cycle Re-oxygenation - Surviving hypoxic cells move to more sensitive (oxic) state before next exposure the LQR model accounts for cellular diversity through the dispersion about the mean radio-sensitivity . The average SF is obtained by assuming a Gaussian distribution of parameters, thus 3 Extending the LQR model further to include 2-compartments of hypoxic and oxic tumour cells, Horas et al. obtained 4 with And comparing to experimental data of Buffa et al. 5 of a human colon adenocarcinoma cell line obtained various tabulated radio-sensitivity parameter values dependent on tumour size 4. Investigated are various forms of repopulation for the oxic portion of cells, conventional and accelerated treatment protocols, whilst observing the changing proportions of the subpopulations and their dynamics throughout (changing R and therefore changing radio-sensitivity parameters calculated using Lagrange interpolation). Figure 2: Parameter values: R 0 =375  m, D=2 Gy, t 2 =80 days, weekday treatments for 6 weeks. (left) Changing dynamics, proportions and therefore radio-sensitivity parameters of subpopulations within tumour throughout treatment schedule given different types of repopulation. (right) Fixed radio-sensitivity parameters at start of treatment schedule determined by weighted averages for different types of re-growth laws. The 2-compartment LQR model & Repopulation Extending the LQ model to include: Redistribution - Asynchronous cycling cell population, preferentially spare cells in resistant part of cell cycle Re-oxygenation - Surviving hypoxic cells move to more sensitive (oxic) state before next exposure the LQR model accounts for cellular diversity through the dispersion about the mean radio-sensitivity . The average SF is obtained by assuming a Gaussian distribution of parameters, thus 3 Extending the LQR model further to include 2-compartments of hypoxic and oxic tumour cells, Horas et al. obtained 4 with And comparing to experimental data of Buffa et al. 5 of a human colon adenocarcinoma cell line obtained various tabulated radio-sensitivity parameter values dependent on tumour size 4. Investigated are various forms of repopulation for the oxic portion of cells, conventional and accelerated treatment protocols, whilst observing the changing proportions of the subpopulations and their dynamics throughout (changing R and therefore changing radio-sensitivity parameters calculated using Lagrange interpolation). Figure 2: Parameter values: R 0 =375  m, D=2 Gy, t 2 =80 days, weekday treatments for 6 weeks. (left) Changing dynamics, proportions and therefore radio-sensitivity parameters of subpopulations within tumour throughout treatment schedule given different types of repopulation. (right) Fixed radio-sensitivity parameters at start of treatment schedule determined by weighted averages for different types of re-growth laws. Table1: Previous work 1 were typical  values are Gy, specifically Adv. Head & neck  = 20 Gy Non-small-cell lung  = 10 Gy Prostate  = 1 Gy Note lack of eradication in Gompertz case